Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis

Journal of Experimental Medicine

Volumn 188, Issue 7, 1998, Pages 1353-1358

  Schiller, Brigitte ^a   He, Chun ^a   Salant, David J ^b   Lim, Alice ^a   Alexander, Jessy J ^a   Quigg, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Complement regulation; Crry; Glomerulus; Heymann nephritis

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; FEMALE; HEYMANN NEPHRITIS; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, SURFACE; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLOMERULONEPHRITIS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT;

EID: 0032487498     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.7.1353     Document Type: Article

References (42)

1. Salant, D.J., and A.V. Cybulsky. 1988. Experimental glomerulonephritis. Methods Enzymol. 162:421-461.
2. Kerjaschki, D., and T.J. Neale. 1996. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J. Am. Soc. Nephrol. 7:2518-2526.
3. Salant, D.J., S. Belok, M.P. Madaio, and W.G. Couser. 1980. A new role for complement in experimental membranous nephropathy in rats. J. Clin. Invest. 66:1339-1350.
4. Makker, S.P. 1993. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. J. Immunol. 151:6500-6508.
5. Cybulsky, A.V., H.G. Rennke, I.D. Feintzeig, and D.J. Salant. 1986. Complement-induced glomerular epithelial cell injury: role of the membrane attack complex in rat membranous nephropathy. J. Clin. Invest. 77:1096-1107.
6. Quigg, R.J., A.V. Cybulsky, J.B. Jacobs, and D.J. Salant. 1988. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int. 34:43-52.
7. Baker, P.J., R.F. Ochi, M. Schulze, R.J. Johnson, C. Campbell, and W.G. Couser. 1989. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am. J. Pathol. 135:185-194.
8. Kerjaschki, D., and M.G. Farquhar. 1982. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl. Acad. Sci. USA 79:5557-5581.
9. Pietromonaco, S., D. Kerjaschki, S. Binder, R. Ullrich, and M.G. Farquhar. 1990. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc. Natl. Acad. Sci. USA. 87:1811-1815.
10. Farquhar, M.G., A. Saito, D. Kerjaschki, and R.A. Orlando. 1995. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J. Am. Soc. Nephrol. 6:35-47.
11. Raychowdhury, R., G. Zheng, D. Brown, and R.T. McCluskey. 1996. Induction of Heymann nephritis with a gp330/megalin fusion protein. Am. J. Pathol. 148:1613-1623.
12. Wong, W., and D.T. Fearon. 1985. p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J. Immunol. 134:4048-4056.
13. Paul, M.S., M. Aegerter, S.E. O'Brien, C.B. Kurtz, and J.H. Weis. 1989. The murine complement receptor gene family. I. Analysis of mCRY gene products and their homology to human CR1. J. Immunol. 142:582-589.
14. Foley, S., B. Li, M. Dehoff, H. Molina, and V.M. Holers. 1993. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur. J. Immunol. 23:1381-1384.
15. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V.M. Holers. 1993. Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295-4305.
16. Kim, Y.-U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L.M. Wagner, and V.M. Holers. 1995. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:151-159.
17. Quigg, R.J., B.P. Morgan, V.M. Holers, S. Adler, A.E. Sneed, and C.F. Lo. 1995. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int. 48:412-421.
18. Funabashi, K., N. Okada, S. Matsuo, T. Yamamoto, B.P. Morgan, and H. Okada. 1994. Tissue distribution of complement regulatory membrane proteins in rats. Immunology. 81: 444-451.
19. Nomura, A., K. Nishikawa, Y. Yuzawa, H. Okada, N. Okada, B.P. Morgan, S.J. Piddlesden, M. Nadai, T. Hasegawa, and S. Matsuo. 1995. Tubulointerstitial injury induced in rats by a monoclonal antibody which inhibits function of a membrane inhibitor of complement. J. Clin. Invest. 96:2348-2356.
20. Quigg, R.J., A.V. Cybulsky, and D.J. Salant. 1991. Effect of nephritogenic antibody on complement regulation in cultured rat glomerular epithelial cells. J. Immunol. 147:838-845.
21. Quigg, R.J., V.M. Holers, B.P. Morgan, and A.E. Sneed. 1995. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J. Immunol. 154:3437-3443.
22. Sakurada, C., H. Seno, N. Dohi, H. Takizawa, M. Nonaka, N. Okada, and H. Okada. 1994. Molecular cloning of the rat complement regulatory protein, 512 antigen. Biochem. Biophys. Res. Commun. 198:819-826.
23. Quigg, R.J., C.F. Lo, J.J. Alexander, A.E. Sneed, and G. Moxley. 1995. Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics. 42:362-367.
24. He, C., J.J. Alexander, A. Lim, and R.J. Quigg. 1997. Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris. Arch. Biochem. Biophys. 341: 347-352.
25. Ridge, S.C., A.L. Oronsky, and S.S. Kerwar. 1988. Type II collagen-induced arthritis in rats. Methods Enzymol. 162: 355-360.
26. Quigg, R.J., D.R. Abrahamson, A.V. Cybulsky, J. Badalamenti, A.W.M. Minto, and D.J. Salant. 1989. Studies with antibodies to cultured rat glomerular epithelial cells: subepithehal immune deposit formation after in vivo injection. Am. J. Pathol. 134:1125-1133.
27. Quigg, R.J., A. Lim, M. Haas, J.J. Alexander, C. He, and M.C. Carroll. 1998. Immune complex glomerulonephritis in C4-and C3-deficient mice. Kidney Int. 53:320-330.
28. Takizawa, H., N. Okada, and H. Okada. 1994. Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J. Immunol. 152:3032-3038.
29. 1-integrin on glomerular epithelial cells and inhibits adhesion and growth. Am. J. Physiol. 262:F770-F776.
30. Susani, M., M. Schulze, M. Exner, and D. Kerjaschki. 1994. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Am. J. Pathol. 144: 807-819.
31. Salant, D.J., Y. Natori, and F. Shimizu. 1997. Glomerular injury due to antibody alone. In Immunologic Renal Diseases. E.G. Neilson and W.G. Couser, editors. Lippincott-Raven, Philadelphia. 359-375.
32. Raychowdhury, R., J.L. Niles, R.T. McCluskey, and J.A. Smith. 1989. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 244:1163-1165.
33. Quigg, R.J., A. Nicholson-Weller, A.V. Cybulsky, J. Badalamenti, and D.J. Salant. 1989. Decay accelerating factor regulates complement activation on glomerular epithelial cells. J. Immunol. 142:877-882.
34. Nakanishi, I., A. Moutabarrik, T. Hara, M. Hatanaka, T. Hayashi, T. Syouji, N. Okada, E. Kitamura, Y. Tsubakihara, M. Matsumoto, and T. Seya. 1994. Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur. J. Immunol. 24:1529-1535.
35. Hinglais, N., M.D. Kazatchkine, S. Bhakdi, M.D. Appay, C. Mandet, J. Grossetete, and J. Bariety. 1986. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 30:399-410.
36. Schulze, M., J.V. Donadio, Jr., C.J. Pruchno, P.J. Baker, R.J. Johnson, R.A.K. Stahl, S. Watkins, D.C. Martin, R. Wurzner, O. Gotze, and W.G. Couser. 1991. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int. 40:533-538.
37. Lehto, T., E. Honkanen, A.M. Teppo, and S. Meri. 1995. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int. 47:1403-1411.
38. Weisman, H.F., T. Bartow, M.K. Leppo, H.C. Marsh, Jr., G.R. Carson, M.F. Concino, M.P. Boyle, K.H. Roux, M.L. Weisfeldt, and D.T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:146-151.
39. Kalli, K.R., P. Hsu, and D.T. Fearon. 1994. Therapeutic uses of recombinant complement protein inhibitors. Springer Semin. Immunopathol. 15:417-431.
40. Moore, F.D., Jr. 1994. Therapeutic regulation of the complement system in acute injury states. Adv. Immunol. 56:267-299.
41. Couser, W.G., R.J. Johnson, B.A. Young, C.G. Yeh, C.A. Toth, and A.R. Rudolph. 1995. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J. Am. Soc. Nephrol. 5: 1888-1894.
42. Higgins, P.J., K. Jone-Long, R. Lobell, C. Sardonini, M.K. Alessi, and C.G. Yeh. 1997. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J. Immunol. 158:2872-2881.